13F Holdings
中文EN

HSCS HeartSciences Inc.

Finance Services · Nasdaq · SEC CIK 1468492 · Fiscal year ends 04/30

Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-17.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin60.9%
Operating margin-209,733.1%
Net margin-227,024.2%
FCF margin—
EBITDA margin-209,135.3%

Returns

ROE-1,851.9%
ROA-201.7%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets154.4%
Debt / equity—
Current ratio0.14x
Interest coverage-11.78x

Cash quality & payout

Operating cash flow / net income0.66x
Accruals ratio-68.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-04-30FY20252025-04-30FY20242024-04-30FY20232023-04-30FY20222022-04-30
Income statement
Revenue$4,319$4,350$18,600$5,150$14,373
Cost of revenue$1,768$1,880$6,081$2,796$7,890
Gross profit$2,551$2,470$12,519$2,354$6,483
R&D expense$2.84M$4.39M$2.88M$2.46M$3.00M
SG&A expense$5.58M$3.97M$3.44M$3.65M$1.71M
Operating income-$8.41M-$8.35M-$6.31M-$6.11M-$4.71M
Interest expense$753,041$500,453$354,080$243,174$371,619
Income tax$0$0———
Net income-$9.14M-$8.77M-$6.61M-$6.35M-$4.83M
EBITDA-$8.39M-$8.31M-$6.28M-$6.09M-$4.68M
EPS (basic)-3.48-9.34-18.74-80.00-1.45
EPS (diluted)—-9.34-18.74-80.00-1.45
Dividends declared per share0.000.00———
Weighted avg. shares (diluted)—938,257352,52079,5063.32M
Balance sheet
Cash & equivalents$1.66M$1.10M$5.81M$1.66M$918,260
Receivables—$4,350——$2,321
Inventory$655,629$650,267$629,179$676,359$674,139
Current assets$2.58M$2.17M$7.35M$2.70M$1.93M
PP&E, net$39,312$63,549$97,991$61,428$70,035
Intangibles$1.66M$1.62M$1.59M——
Total assets$5.26M$4.22M$9.50M$3.29M$2.09M
Current liabilities$4.86M$3.70M$1.75M$1.83M$3.47M
Total liabilities$5.04M$4.02M$2.19M$3.06M$8.15M
Shareholders' equity$226,060$205,171$7.32M$230,557-$6.06M
Shares outstanding3.19M1.12M676,598101,3323.32M
Cash flow statement
Operating cash flow-$7.43M-$7.41M-$6.07M-$5.77M-$3.64M
Capital expenditure$3,554$3,157$64,455$18,308$1,932
Free cash flow-$7.43M-$7.42M-$6.13M-$5.79M-$3.65M
Investing cash flow-$44,452-$30,188-$125,271-$18,308-$1,932
Financing cash flow$8.03M$2.73M$10.34M$6.53M$3.84M
Depreciation & amortization$27,791$37,599$27,892$26,915$26,566
Stock-based compensation$1.31M$249,884$405,025$248,307$68,396

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.